查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球醫用仿生植入物市場-2022-2029
市場調查報告書
商品編碼
1140710

全球醫用仿生植入物市場-2022-2029

Global Medical Bionic Implant Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

預計 2021 年醫用仿生植入物市場規模將達到 237.36 億美元，2029 年將達到 415.89 億美元，在預測期間（2022-2029 年）的複合年增長率為 8.7%。預計。

仿生學是生物學和電子學的結合。它是將一種特殊類型的裝置或假體植入人體，以再現原始器官的功能。醫學仿生學通過自動適應來替換或改善身體的不同部位。先進的仿生植入物提供優於傳統假肢的優勢，包括減少疲勞和不適以及實時控制。醫用仿生植入物被歸類為假器官，因為它們完美地模仿了自己的能力或表現出超越它們的改進。

市場動態

不斷增長的需求推動市場增長，交通事故增加，老年人口增加，個人慢性病數量增加，器官衰竭，傷害和事故數量增加，以及對醫學仿生學的需求。職業殘疾可以改善問題.

醫療技術的不斷進步和慢性病患病率的上升預計將推動市場的增長。

醫療技術的不斷進步正在推動醫療仿生植入物市場的發展。此外，公眾對各種疾病的認識不斷提高，醫用仿生植入物和人工器官手術的進步，以及對各種疾病進行早期診斷和治療的篩查需求，也推動了醫用仿生植入物市場的發展。

此外，世界各地許多人患有糖尿病和外周動脈疾病等血管疾病，增加了截肢的可能性。在美國，據說大約有 200 萬人患有截肢者。根據美國國家衛生統計中心的數據，美國每年進行 185,000 次截肢手術，據估計，目前該國約有 200 萬人與截肢者一起生活。醫用仿生植入物和市場的快速發展導致了新機器人技術的開發和改進。醫療器械製造商之所以轉向新興市場，主要是因為它們的人口眾多以及對仿生替代品的持續需求。

此外，越來越多的截肢手術加上高科技生物材料植入物的功能不斷增加，也促進了醫用仿生植入物和外骨骼市場的增長。這些因素正在推動醫用仿生植入物市場的增長。

仿生手臂的發展將刺激市場的增長。 2020 年 2 月，作為仿生手臂假肢開發的下一個裡程碑，維也納醫科大學與麻省理工學院（Extreme Bionics Center）和維也納大學電氣工程系合作哥德堡，維也納醫科大學外科奧斯卡阿斯曼團隊在肢體重建臨床實驗室的仿生開發了世界上第一個完全集成的仿生手臂假肢，可以使用。第一次，系統是獨立的，一切都直接發生在你的手臂上。電池直接插入假肢，晚上可以輕鬆取出和充電。

由於醫療領域的快速技術進步以及對醫用仿生植入物和人造器官的需求不斷增長，預計全球醫用仿生植入物市場將在預測期內強勁發展。

此外，仿生學的概念已被應用到其他領域，例如用於建造士兵穿戴的外骨骼的防禦。這種外骨骼和仿生服可以幫助士兵攜帶重物並提高他們在戰場上的機動性。仿生設備正在開發中，其功能範圍從解剖學上正確的印刷假肢和美容細節到智能手機控制命令。

預計不斷上漲的醫療成本和設備故障將阻礙市場增長。

高昂的治療成本、昂貴的設備、故障設備、有限的手術專業知識以及因地區而異的不確定報銷方案等因素阻礙了市場增長。

行業分析

全球醫用仿生植入物市場根據包括波特五力、監管分析、供應鏈分析和定價分析在內的各種行業因素對市場進行了深入分析。

細分分析

心臟仿生部分有望在全球醫用仿生植入物市場中佔據最大市場份額

醫療仿生植入物市場根據視覺仿生、心臟仿生、骨科仿生、耳仿生、腦仿生等進行細分。其中，由於心血管疾病的高發病率，心臟仿生學佔據了最大的市場份額。預計 Earbionics 將在預測期內佔據很大的市場份額。患者更喜歡這些設備，因為它們比藥物更容易、更舒適。

骨科仿生學是人體各個部位骨骼的人工替代品或替代品。髖關節、膝關節、肘關節、踝關節、腿等是典型的假肢。根據 2020 年斯坦福兒童健康報告，估計有 350 萬運動傷害，這一數字有望成為市場驅動力。 Brain Bionics 是一種專門針對通過將植入物插入人的頭部而導致抑鬱的錯誤大腦活動的治療方法。

此外，從技術角度來看，市場分為植入式和外部可穿戴設備。由於使用量的增加，植入物佔據了最高的市場份額。它用於起搏器、RFID 標籤、神經刺激器和許多其他具有無線通信能力的植入物。黑色金屬堅固而堅硬，幾乎不受極端環境的影響。然而，由於其磁性，應盡量減少暴露於其他磁場。

由於與非技術用戶相比，對身體形象的需求不斷增加，外部可穿戴設備是一個市場有望增長的領域。在適當的情況下，這些數據可用於識別潛在問題，制定緩解這些問題的策略，並在糖尿病患者考慮採用外部技術時為他們提供信息。

區域分析

北美在全球醫用仿生植入物市場中佔有最大的市場份額

醫用仿生植入物市場按地區劃分為北美、南美、歐洲、亞太地區、中東和非洲。由於對技術先進產品的需求以及政府強有力的研發計劃和患者的高意識水平，北美等地在醫用仿生植入物市場中佔據主導地位。此外，北美是眾多研究實驗室、生物技術公司和醫療器械製造公司的所在地，預計它們將為市場的增長做出貢獻。此外，有利的醫療補償計劃和對器官移植的高需求也有望推動北美市場的增長。

由於其龐大的不斷增長的消費者基礎、政府加強醫療保健的努力以及高可支配收入，預計亞太地區將佔據較大的市場份額。印度和中國的快速發展以及患者意識水平的提高是該地區增長的主要驅動力。幾個國家的政府和監管機構正在採取協調一致的措施，以確保醫療仿生植入物市場的持續需求。世界銀行表示，亞太地區國家的外國直接投資顯著增加。馬來西亞、印度尼西亞和印度等新興市場的經濟增長率遠高於發達國家。因此，預計這些國家將在醫療保健領域進行更多投資，從而振興全球醫用仿生植入物市場。

競爭格局

許多來自日本和國外的公司已進入市場。技術進步、新產品發布和具有成本效益的解決方案增加了市場競爭。 Orthofix International N.V.、Touch Bionics Inc、Second Sight Medical Products, Inc、Ekso Bionics、St. Jude Medical, Inc、Lifenet Health Inc 和 Otto Bock Inc 是市場份額較大的主要參與者。

公司專注於開發和升級現有機器，以提高年生產率並優化加工操作流程。例如，2019 年科利耳推出了世界上第一個有源骨整合固定植入物 Osia。它使用數字壓電刺激將聲音振動直接傳遞到耳蝸，繞過聽覺系統的受損區域。

公司正在開展研究合作、合併、戰略合作夥伴關係和收購，以增加對生物標誌物的需求並在全球範圍內擴張。例如，2020 年 6 月，專注於肌肉骨骼癒合產品的全球醫療器械公司 Orthofix Medical Inc. 宣布獲得美國食品藥品監督管理局（Food and Drug Administration）的批准和第一個患者植入物 FIREBIRD SI Fusion System。 FIREBIRD SI Fusion System 是美國發布的第一款 3D 打印鈦合金 SI 關節骨螺釘，旨在壓縮和穩定□髂關節（SI 關節）。 FIREBIRD SI 融合系統設計有一個多孔的中心軸，骨骼在其上生長，在 SI 關節處在植入物和患者骨骼之間建立結合。

值得關注的重點公司

Ekso Bionics Holdings Inc：

概述 Ekso Bionics 是一種動力外骨骼，可用作可穿戴機器人，以提高癱瘓患者以及中風或嚴重受傷後行動不便的人的耐力、運動能力和力量。一家開發 nick 設備的仿生設備公司。成立於2005年，總部位於美國加利福尼亞州。

按產品類型劃分的產品組合

Ekso EVO：一種支持上半身的外骨骼，可增加耐力並減輕繁重任務的壓力。建立在 EksoVest 技術之上。

重大進展。 2020 年 6 月，Ekso Bionics 控股公司宣布美國 FDA 批准 EksoNR 用於創傷性腦損傷患者。

全球醫用仿生植入物市場報告提供大約 45 多個市場數據表、40 多個數字和 180 頁。

內容

第1章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 慢性病發病率增加
      • 醫療技術的進步
    • 限制因素
      • 治療費用飆升
      • 設備故障
    • 商機
    • 影響分析

第五章行業分析

  • 波特五力分析
  • 監管分析
  • 供應鏈分析
  • 定價分析

第 6 章按產品類型分析

  • 視覺仿生學
  • 心臟仿生學
    • 輔助人工心臟
    • 全人工心臟
    • 人工心臟瓣膜
    • 起搏器
  • 用於骨科手術的仿生學
    • 仿生手
    • 仿生腿
    • 仿生肢體
  • 耳仿生學
    • 骨傳導助聽器
    • 人工耳蝸
  • 腦仿生學
    • 深部腦刺激器
    • 迷走神經刺激器
    • 脊髓刺激器
  • 其他

第 7 章按技術分類

  • 機械
  • 電子

第8章固定方法

  • 種植體類型
  • 外戴型

第 9 章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 10 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 按產品類型進行基準測試
  • 值得關注的重點公司列表

第 11 章公司簡介

  • Ekso Bionics Holdings, Inc.
  • Touch Bionics Inc.
  • 生命網健康股份有限公司
  • 愛德華茲生命科學有限公司
  • Orthofix Holdings, Inc.
  • Livanova PLC
  • 彩虹醫療集團
  • 波士頓科學公司

第 12 章全球醫用仿生植入物市場-DataM

簡介目錄
Product Code: DMMD2573

Market Overview

Medical Bionic Implant Market size was valued US$ 23,736 million in 2021 and is estimated to reach US$ 41,589 million by 2029, growing at a CAGR of 8.7% during the forecast period (2022-2029).

Bionics incorporates biology with electronics. It implants the special types of instruments or prosthetics that have been inserted into the human body to replicate the original organ function. Medical Bionics replaces or improves different parts of the body with automated adaptations. Advanced bionic implants have advantages over traditional prostheses, such as less tiredness, discomfort, and control in real-time. Medical bionic implants are assorted from the counterfeit organ as they mimic unique capacity completely or even show improvement over it.

Market Dynamics

The rising demand drives the market growth, increasing road accidents, growing geriatric population, rising number of chronic diseases among individuals, organ failure, increasing injuries and accidents, and occupational disabilities that demand medical bionic improve the problem.

Growing advancements in medical technologies and rising prevalence of chronic diseases are expected to drive market growth.

Growing advancements in medical technologies are fueling the medical bionic implant market. Growing public awareness about various diseases, advancements in medical bionic implant and artificial organ procedures, and the need for screenings conducted for early diagnosis and treatment of various diseases are also expected to favor the medical bionic implant market.

Moreover, people worldwide suffer from vascular diseases, including diabetes and peripheral arterial diseases, which increase the chances of amputations. In the U.S., there are about two million people who are living with limb loss. As per data from the National Center for Health Statistics, 185,000 amputations are conducted in the U.S. every year, and roughly 2 million people in the country are currently living with a lost limb. Rapid advancements in the medical bionic implants and market have led to new and improved robotics technology. Medical device makers are looking at emerging economies mainly because of their large populations and continued demand for bionic replacements.

Besides, a greater number of amputations coupled with improved capabilities of high-tech biomaterial-based implants contribute to the growth of the medical bionic implants and exoskeletons market. These factors are driving the growth of the medical bionic implant market.

The development of bionic arms shall stimulate market growth. In February 2020, the next milestone in the development of bionic arm prostheses with a major contribution from the Medical University of Vienna, in collaboration with the Massachusetts Institute of Technology (Center for Extreme Bionics) and the Department of electrical engineering at the University of Gothenburg, Oskar Aszmann's team in the clinical laboratory for bionic limb reconstruction at Meduni Vienna's department of surgery has developed the world's first fully-integrated bionic arm prosthesis that is ready to use. For the first time, this system is self-contained, and everything takes place directly in the arm. The battery inserts directly into the prosthesis and can easily be removed in the evening for recharging.

With quick technological advancement, rapid technological advancements in the medical field, the ever-increasing demand for medical bionics implants and artificial organs, the global medical bionic implant market is anticipated to develop during the forecast period vigorously.

Moreover, the concept of bionics is applied in other fields, such as the defense to build exoskeletons, which soldiers can wear. These exoskeleton suits or bionic suits help them carry heavy loads and improve their mobility on the battlefield. Bionic devices are being developed with various features such as printed prostheses with anatomically correct shapes along with cosmetic details and smartphone-controlled commands.

High cost of treatment and malfunction of device are expected to hamper the market growth.

The market is hindered by factors such as high cost of treatment, expensive devices, malfunction of devices, limited surgical expertise, and uncertain reimbursement scenarios in different regions are restraining the market's growth.

Industry Analysis

The global medical bionic implant market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, supply chain analysis, pricing analysis.

Segment Analysis

Heart bionics segment is expected to hold the largest market share in global medical bionic implant market

Medical bionic implant market is segmented based on vision bionics, heart bionics, orthopedic bionics, ear bionics, brain bionics, etc. Among these, heart bionics held the largest market share due to the high prevalence of cardiovascular disorders. Ear bionics are expected to gain substantial market share during the forecast period. These devices are preferred more by the patients owing to the ease and comfort they provide than drugs.

Orthopedic bionics an artificial replacement or substitute of bones in different parts of the body. The typical orthopedic prosthetic devices are for the hip, knee, elbow, ankle, and leg. According to Stanford Children's Health 2020, there were an estimated 3.5 million sports injuries occurred; this significant number is expected to act as a driver to the market growth. Brain bionics are involved in inserting an implant inside a person's head to specifically target faulty brain activity associated with making a person stay "stuck" in their depression.

Further, the market is also classified based on technology as Implantable and Externally Worn. The Implantable segment accounts for the highest market share due to the rising usage. These materials are used pacemakers, RFID tags, neurostimulators, and various other implants with wireless communication functions. The robust and rigid nature of ferrous metals leaves them nearly unaffected by extreme elements. However, their magnetic properties mean exposure to other magnetic fields must be minimized.

The Externally Worn segment is expected to have positive market growth due to the rising demand for body image compared to nontechnology users. Where appropriate, these data can be used to identify potential concerns, address strategies to mitigate them and inform people with diabetes when considering adopting external technologies.

Geographical Analysis

North America region holds the largest market share in the global medical bionic implant market

The medical bionic implant market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa based on the region. Among all of the regions, North America dominated the medical bionic implant market due to the demand for technologically advanced products coupled with strong R&D initiatives by the government and high patient awareness levels. Moreover, many research laboratories, biotechnology, and medical devices manufacturing companies in North America are projected to contribute to its growth. Also, the favorable healthcare compensation plans and high demand for organ transplantation are expected to propel the market's growth in North America.

The Asia Pacific is expected to have a significant market share due to the rising to a large consumer base, rising government initiatives for enhancing healthcare, and high disposable income. Rapidly developing India and China regions and growing patient awareness levels in this region are the major factors contributing to this region's growth. In several countries, national governments and regulatory bodies take collaborative measures to ensure a constant demand for the medical bionic implants market. The World Bank states that countries in the Asia-Pacific region have witnessed a marked rise in FDI. Emerging markets such as Malaysia, Indonesia, and India have recorded much higher economic growth rates than developed nations. This is expected to drive higher investment across the healthcare sector in all of these countries, boosting the global medical bionic implant market.

Competitive Landscape

Several local and international players are present in the market. The technological advancement, new product launches, availability of cost-effective solutions intensify the market competition. Orthofix International N.V., Touch Bionics Inc., Second Sight Medical Products, Inc., Ekso Bionics, St. Jude Medical, Inc., Lifenet Health Inc., and Otto Bock Inc. are the leading market players with significant market share.

Companies focus on developing and upgrading existing machinery to increase annual productivity and optimize processing operational flow. For instance, In 2019, Cochlear announced world's 1st active osseo-integrated steady state implant, Osia. It utilizes digital piezoelectric stimulation that bypass the damaged areas of hearing system by which sound vibrations directly reaches to cochlea.

The companies are entering into collaborations, mergers, strategic partnerships, and acquisitions to increase the demand for biomarkers and their expansion across the globe. For instance, in June 2020, Orthofix Medical Inc., a global medical device company focused on musculoskeletal healing products, announced the U.S. Food and Drug Administration clearance and the first patient implants FIREBIRD SI Fusion System. Designed to compress and stabilize the sacroiliac joint (also called the SI joint) during fusion, the FIREBIRD SI Fusion System is the first 3D printed titanium bone screw to launch in the U.S. for treating SI joint. The FIREBIRD SI Fusion System is designed with a porous mid-shaft region that allows the bone to grow into its surface - creating a bond between the implant and the patient's bone at the SI joint.

Key Companies to Watch

Ekso Bionics Holdings Inc.:

Overview: Ekso Bionics is a bionic devices company that develops powered exoskeleton bionic devices that can be impoverished as wearable robots to increase the endurance, mobility and strength of people with paralysis and suffering from mobility issues after stroke or serious injury. It was founded in 2005 and is headquartered in California, United States.

Product Type Portfolio:

Ekso EVO: It is an assistive upper body exoskeleton that is endurance boosting and lightens the pressure of monotonous work. It is built on EksoVest technology.

Key Developments: In Jun 2020, Ekso Bionics holdings announced approval for its EksoNR by U.S.FDA to use on traumatic brain injury patients.

The global medical bionic implant market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers:
      • 4.1.1.1. Rising Incidence of Chronic Diseases
      • 4.1.1.2. Increasing medical technological advancements
    • 4.1.2. Restraints:
      • 4.1.2.1. High cost of treatment
      • 4.1.2.2. Malfunctioning of device
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Regulatory Analysis
  • 5.3 Supply Chain Analysis
  • 5.4 Pricing Analysis

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Vision Bionics
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, USD Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 6.3. Heart Bionics
    • 6.3.1. Ventricular assist device
    • 6.3.2. Total artificial heart
    • 6.3.3. Artificial heart valve
    • 6.3.4. Pacemaker
  • 6.4. Orthopedic Bionics
    • 6.4.1. Bionic hand
    • 6.4.2. Bionic leg
    • 6.4.3. Bionic limb
  • 6.5. Ear Bionics
    • 6.5.1. Bone anchored hearing aid.
    • 6.5.2. Cochlear implant
  • 6.6. Brain Bionics
    • 6.6.1. Deep brain stimulator
    • 6.6.2. Vagus nerve stimulator
    • 6.6.3. Spinal cord stimulator
  • 6.7. Others

7. By Technology

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 7.1.2. Market Attractiveness Index, By Technology
  • 7.2. Mechanical
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, USD Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Electronic

8. By Method of Fixation

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method of Fixation
    • 8.1.2. Market Attractiveness Index, By Method of Fixation
  • 8.2. Implantable
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, USD Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Externally Worn

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method of Fixation
    • 9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method of Fixation
    • 9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method of Fixation
    • 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method of Fixation
    • 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. Australia
      • 9.5.6.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method of Fixation

10. Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Product Types Benchmarking
  • 10.4. List of Key Companies to Watch

11. Company Profiles

  • 11.1. Ekso Bionics Holdings, Inc.

a. Company Overview

b. Product Type Portfolio and Description

c. Key Highlights

d. Financial Overview

  • 11.2. Touch Bionics Inc.
  • 11.3. LifeNet Health Inc.
  • 11.4. Edwards Lifesciences Corporation
  • 11.5. Orthofix Holdings, Inc.
  • 11.6. LivaNova PLC
  • 11.7. Rainbow Medical Group
  • 11.8. Boston Scientific Corporation

LIST NOT EXHAUSTIVE

12. Global Medical Bionic Implant Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and Method of Fixation
  • 12.3. Contact Us